CD33 and proximal spinal muscular atrophy: This approach revealed that the levels of SMN protein expression in PBCs from the SMA subjects was significantly reduced compared with those from the control subjects in the populations of CD3+ cells (R2), CD19+ cells (R3), and CD33++ cells (R4).